Protective effects of emodin against cisplatin-induced oxidative stress in cultured human kidney (HEK 293) cells

Journal of Applied Toxicology

Volumn 33, Issue 7, 2013, Pages 626-630

  Waly, Mostafa I ^a   Ali, Badreldin H ^a   Al Lawati, Intisar ^a   Nemmar, Abderrahim ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Antioxidants; Cisplatin; Emodin; Oxidative stress

Indexed keywords

CATALASE; CISPLATIN; EMODIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; SCAVENGER; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; RENAL PROTECTION;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CELL SURVIVAL; CHROMANS; CISPLATIN; COLORING AGENTS; EMODIN; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; FREE RADICALS; HEK293 CELLS; HUMANS; OXIDATIVE STRESS; PICRATES;

RHEUM X HYBRIDUM;

EID: 84878209762     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1788     Document Type: Article

References (25)

1. Ali BH, Al Moundhri MS. 2006. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem. Toxicol. 44: 1173-1183.
2. Buring JE, Hennekens CH. 1997. Antioxidant vitamins and cardiovascular disease. Nutr. Rev. 55: S53-S58.
3. Chang CH, Lin CC, Yang JJ, Namba T, Hattori M.1996. Anti-inflammatory effects of emodin from Ventilago leiocarpa. Am. J. Chin. Med. 24: 139-142.
4. Chang YC, Lai TY, Yu CS, Chen HY, Yang JS, Chueh FS, Lu CC, Chiang JH, Huang WW, Ma CY, Chung JG. 2011. Emodin induces apoptotic death in murine myelomonocytic leukemia WEHI-3 cells in vitro and enhances phagocytosis in leukemia mice in vivo. Evid. Based Complement. Alternat. Med. 2011: 523596; epub 2011 May 10.
5. Chirino YI, Pedraza-Chaverri J. 2009. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp. Toxicol. Pathol. 61: 223-242.
6. Ding Y, Zhao L, Mei H, Zhang SL, Huang ZH, Duan YY, Ye P. 2008. Exploration of emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. Eur. J. Pharmacol. 590: 377-386.
7. Halliwell B, Gutteridge JMC. 2007. Antioxidant defenses endogenous and diet derived. In Free Radicals in Biology and Medicine, 4th edn. Oxford University Press: New York; 79-86.
8. Kuo PL, Lin TC, Lin CC. 2002. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci. 71: 1879-1892.
9. López V, Akerreta S, Casanova E, García-Mina JM, Cavero RY, Calvo MI. 2007. In vitro antioxidant and anti-rhizopus activities of Lamiaceae herbal extracts. Plant Foods Hum. Nutr. 62: 151-155.
10. Lowry OH, Rosebrough NJ, Fait AL, Ramdal RJ. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
11. Malich G, Markovic B, Winder C. 1997. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 124: 179-192.
12. Scheibmeir HD, Christensen K, Whitaker SH, Jegaethesan J, Clancy R, Pierce JD. 2005. A review of free radicals and antioxidants for critical care nurses. Intens. Crit. Care Nurs. 21: 24-28.
13. Schiffrin EL. 2010. Antioxidants in hypertension and cardiovascular disease. Mol. Interv. 10: 354-362.
14. Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison L. 2002. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. J. Am. Soc. Nephrol. 13: 1733-1739.
15. Shieh YS, Lee HS, Shiah SG, Chu YW, Wu CW, Chang LC. 2004. Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. J. Oral Pathol. Med. 33: 601-606.
16. Srinivas SK, Reddy, KS, Vivekanandam S, Parthasarathy V. 2005. Role of template guided interstitial implants in breast conservation therapy. J. Cancer Res. Ther. 1: 79-83.
17. Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U. 2005. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Cancer 103: 1302-1313.
18. Taguchi A, Takahashi T, Harima Y, Takemoto Y, Ando T, Nomiyama J, Matsubara A, Yujiri T, Tanizawa Y. 2005. All-trans retinoic acid-induced erythema nodosum in acute promyelocytic leukemia. Rinsho Ketsueki 46: 202-205.
19. Tan AC, Konczak I, Sze DM, Ramzan I. 2011. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr. Cancer 63: 495-505.
20. Waly MI, Al Moundhri MS, Ali BH. 2011. Effect of Curcumin on cisplatin and oxaliplatin-induced oxidative stress in Human embryonic kidney (HEK) 293 cells. Ren. Fail. 33: 518-523.
21. Wang HH, Chung JH. 1997. Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori. Curr. Microbiol. 35: 262-266.
22. Wang R, Wan Q, Zhang Y, Huang F, Yu K, Xu D, Wang Q, Sun J.2007. Emodin suppresses interleukin-1beta induced mesangial cells proliferation and extracellular matrix production via inhibiting P38 MAPK. Life Sci. 80: 2481-2488.
23. Yang FC, Pei W. 2008. Graphite furnace atomic absorption spectrometry direct determination of urine thallium. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 26: 486-487.
24. Yao X, Panichpisal K, Kurtzman N, Nugent K. 2007.Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 334: 115-124.
25. Yon JM, Baek IJ, Lee BJ, Yun YW, Nam SY. 2011. Emodin and [6]-gingerol lessen hypoxia-induced embryotoxicities in cultured mouse whole embryos via upregulation of hypoxia-inducible factor 1α and intracellular superoxide dismutases. Reprod. Toxicol. 31: 513-518.